Assessing Serum Apolipoproteins A‐I and b100 and the Apo A‐I/Apo b100 Ratio in Relation to Premature Coronary Artery Disease and Its Severity
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Zahra Zarepour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Apolipoprotein B-100, Apolipoprotein A-I, Coronary Artery Disease, Coronary Stenosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: This article is taken from disease registry, titled "Coronary Angiography and Angioplasty Registry (CAAR)" and code number "IR.SBMU.RETECH.REC.1400.256" that w….
Abstract (Originalsprache)
Background
Apolipoproteins are proposed to predict the status of CAD and its occurrence. The aim of this study was to assess the association between serum levels of apolipoproteins A‐I, b100 and the ratio of Apo A‐I/Apo b100 with the development and severity of premature coronary artery disease (PCAD).
Methods
In this registry‐based case‐control study, patients under the age of 50 years with at least one coronary artery disease with stenosis ≥ 50% (PCAD group) were assessed and compared with patients without coronary artery involvement (normal group). The Gensini score considered to assess the CAD severity.
Results
The mean Apo A‐I and Apo A‐I/Apo b100 levels were higher in the control group, but Apo b100 was higher in the patient group ( p < 0.05). Apo A‐I and Apo A‐I/Apo b100 ratio had a negative correlations (rho = −0.57, rho = −0.71, respectively) with the severity of PCAD based on the Gensini score. Apo b100 also had a positive correlation (rho = 0.67) with the severity of PCAD ( p < 0.05). Apo A‐I and Apo b100 were significantly associated with the occurrence of PCAD. Based on the results of multivariable analysis, with a 1 mg/dL increase in Apo A‐I levels and Apo b100, the odds of PCAD decreased by 13% and increased by 31%, respectively. With a 1 mg/dL increase in apolipoprotein A‐I and apolipoprotein b100 levels, the odds of high Gensini score decreased by 7% and increased by 8%, respectively ( p = 0.001).
Conclusion
The use of serum apolipoproteins in patients with suspected PCAD can predict the occurrence of CAD and its severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Prevention of Cardiovascular Disease Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Cardiology, Imam Hossein Educational Hospital, Shahid Behehsti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mohammad Parsa Mahjoob, Niloufar Taherpour, Mohammad Haji Aghajani
Förderung
- This article is taken from disease registry, titled "Coronary Angiography and Angioplasty Registry (CAAR)" and code number "IR.SBMU.RETECH.REC.1400.256" that w…
Zitieren
APA
Zarepour, Z., Parsa Mahjoob, M., Taherpour, N., & Haji Aghajani, M. (2025). Assessing Serum Apolipoproteins A‐I and b100 and the Apo A‐I/Apo b100 Ratio in Relation to Premature Coronary Artery Disease and Its Severity. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31497
Vancouver
Zarepour Z, Parsa Mahjoob M, Taherpour N, Haji Aghajani M. Assessing Serum Apolipoproteins A‐I and b100 and the Apo A‐I/Apo b100 Ratio in Relation to Premature Coronary Artery Disease and Its Severity. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31497
BibTeX
@article{Zarepour2025,
author = {Zarepour, Zahra and Parsa Mahjoob, Mohammad and Taherpour, Niloufar and Haji Aghajani, Mohammad},
title = {Assessing Serum Apolipoproteins A‐I and b100 and the Apo A‐I/Apo b100 Ratio in Relation to Premature Coronary Artery Disease and Its Severity},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31497}
}
EUVIMED